Haynes’ global ophthalmology leadership to grow clinical operations at CXLOSHERBORN, Mass. (BUSINESS WIRE) CXL Ophthalmics, Inc., a clinical-stage company developing a minimally-invasive treatment for keratoconus, today announced that Tiffany Haynes has been appointed as Vice President of Clinical Operations.With.